FFCP PHASE1:Mm9::chr18:38540835..38540845,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(4 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |EntrezGene=NA | ||
|HGNC= | |HGNC= | ||
|MCL_coexpression_id=6 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |UniProt=NA | ||
|association_with_transcript=NA | |association_with_transcript=NA | ||
|cluster_id=chr18:38540835..38540845,- | |||
|description=CAGE_peak_at_chr18:38540835..38540845,- | |description=CAGE_peak_at_chr18:38540835..38540845,- | ||
|id=chr18:38540835..38540845,- | |id=chr18:38540835..38540845,- | ||
|ontology_enrichment_celltype=CL:0000815!1.24e-08!1;CL:0000792!1.24e-08!1;CL:0000355!3.67e-08!9 | |ontology_enrichment_celltype=CL:0000815!1.24e-08!1;CL:0000792!1.24e-08!1;CL:0000355!3.67e-08!9 | ||
|ontology_enrichment_celltype_v019_2=CL:0000815,5.53e-12,1;CL:0000792,5.53e-12,1;CL:0000355,1.01e-11,9 | |||
|ontology_enrichment_disease=DOID:0060100!2.82e-23!3;DOID:4045!2.82e-23!3;DOID:0050686!5.76e-12!6 | |ontology_enrichment_disease=DOID:0060100!2.82e-23!3;DOID:4045!2.82e-23!3;DOID:0050686!5.76e-12!6 | ||
|ontology_enrichment_disease_v019_2=DOID:0060100,1.31e-33,3;DOID:4045,1.31e-33,3;DOID:0050686,3.20e-17,6 | |||
|ontology_enrichment_uberon=UBERON:0001134!3.67e-08!9;UBERON:0002036!3.67e-08!9;UBERON:0002385!3.67e-08!9;UBERON:0000486!3.67e-08!9;UBERON:0001015!3.67e-08!9;UBERON:0004290!3.67e-08!9;UBERON:0003082!3.67e-08!9;UBERON:0000383!2.14e-07!10;UBERON:0002329!9.10e-07!11;UBERON:0003077!9.10e-07!11;UBERON:0003059!9.10e-07!11;UBERON:0007282!9.10e-07!11;UBERON:0009618!9.10e-07!11;UBERON:0007285!9.10e-07!11 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,1.01e-11,9;UBERON:0002036,1.01e-11,9;UBERON:0002385,1.01e-11,9;UBERON:0000486,1.01e-11,9;UBERON:0007503,1.01e-11,9;UBERON:0001015,1.01e-11,9;UBERON:0002329,1.01e-11,9;UBERON:0003082,1.01e-11,9;UBERON:0003059,1.01e-11,9;UBERON:0007282,1.01e-11,9;UBERON:0004290,1.01e-11,9;UBERON:0009618,1.01e-11,9;UBERON:0000383,1.29e-10,10;UBERON:0007524,1.04e-09,11;UBERON:0003077,1.04e-09,11;UBERON:0007285,1.04e-09,11 | |||
|phase1_expression=0,0,0,0,0,0,0,1.03298658753261,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.18531630736908,3.1253413780952,1.0470474879476,18.8234076169925,2.73218193983378,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.718890747035522,0,0.381210681219194,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.01987057996313,1.25956307091292,0.414599921413271,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,1.03298658753261,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.18531630736908,3.1253413780952,1.0470474879476,18.8234076169925,2.73218193983378,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.718890747035522,0,0.381210681219194,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.284163499395593,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.01987057996313,1.25956307091292,0.414599921413271,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p@chr18:38540835..38540845,- | |short_description=p@chr18:38540835..38540845,- | ||
}} | }} |
Latest revision as of 18:36, 5 August 2015
Short description: | p@chr18:38540835..38540845, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr18:38540835..38540845, - |
Coexpression cluster: | MCL_coexpression_mm9:6 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
regulatory T cell | 5.53e-12 | 1 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell | 5.53e-12 | 1 |
multi-potent skeletal muscle stem cell | 1.01e-11 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 1.01e-11 | 9 |
striated muscle tissue | 1.01e-11 | 9 |
muscle tissue | 1.01e-11 | 9 |
multilaminar epithelium | 1.01e-11 | 9 |
epithelial vesicle | 1.01e-11 | 9 |
musculature | 1.01e-11 | 9 |
somite | 1.01e-11 | 9 |
myotome | 1.01e-11 | 9 |
presomitic mesoderm | 1.01e-11 | 9 |
presumptive segmental plate | 1.01e-11 | 9 |
dermomyotome | 1.01e-11 | 9 |
trunk paraxial mesoderm | 1.01e-11 | 9 |
musculature of body | 1.29e-10 | 10 |
dense mesenchyme tissue | 1.04e-09 | 11 |
paraxial mesoderm | 1.04e-09 | 11 |
presumptive paraxial mesoderm | 1.04e-09 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 1.31e-33 | 3 |
muscle cancer | 1.31e-33 | 3 |
organ system cancer | 3.20e-17 | 6 |